CSIMarket
 


Akers Biosciences Inc   (AKER)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

AKER's Operating Income Growth by Quarter and Year

Akers Biosciences Inc 's Operating Income results by quarter and year




AKER Operating Income (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter December - -1.32 -2.93 -3.40
III Quarter September -2.97 -0.87 -3.12 -1.18
II Quarter June -3.66 -0.82 -2.11 -0.82
I Quarter March -3.55 -0.94 -1.89 -1.36
FY   -10.18 -3.95 -10.05 -6.76



AKER Operating Income third quarter 2020 Y/Y Growth Comment
Akers Biosciences Inc in the third quarter recorded Operating Loss of $ -2.97 millions.

According to the results reported in the third quarter, Akers Biosciences Inc achieved the best Operating Income growth in Biotechnology & Drugs industry. While Akers Biosciences Inc ' s Operating Income no change of % ranks overall at the positon no. in the third quarter.

Explain Operating Income growth


AKER Operating Income ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Akers Biosciences Inc 's third quarter 2020 Operating Income $ -2.97 millions AKER's Income Statement
Akers Biosciences Inc 's third quarter 2019 Operating Income $ -0.87 millions Quarterly AKER's Income Statement
New: More AKER's historic Operating Income Growth >>


AKER Operating Income (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Operating Income third quarter 2020 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Operating Income third quarter 2020 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Operating Income by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Akers Biosciences Inc 's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


AKER's III. Quarter Q/Q Operating Income Comment
Despite the fact, that Akers Biosciences Inc in the III. Quarter 2020 admitted Operating Loss of $ -2.97 millions, some analyst point out, that those numbers show improvement in contrast to the -3.66 millions in the second quarter.

Within Biotechnology & Drugs industry Akers Biosciences Inc achieved highest sequential Operating Income growth. While Akers Biosciences Inc 's Operating Income growth quarter on quarter, overall rank is .


Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


AKER's III. Quarter Q/Q Operating Income Comment
Even if Akers Biosciences Inc in the III. Quarter 2020 showed Operating Loss of $ -2.97 millions, it should be mentioned, that this show slight up side relative to the -3.66 millions in the second quarter.

Within Biotechnology & Drugs industry Akers Biosciences Inc achieved highest sequential Operating Income growth. While Akers Biosciences Inc 's Operating Income growth quarter on quarter, overall rank is .


Akers Biosciences Inc 's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
Cumulative Operating Income 12 Months Ending $ -11.49 $ -9.39 $ -6.55 $ -3.95 $ -5.56
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) - - - - -
Seq. Operating Income Growth (TTM) Overall Ranking # # # # #




Cumulative Operating Income growth Comment
Akers Biosciences Inc ' has realized cumulative trailing twelve months Operating Loss of $ -11 millions in the Sep 30 2020 period.
The situation is worsening as the cumulative Operating Loss is becoming larger from $ -9.39 millions in TTM ending quarter Jun 30 2020 and $ -3.66 millions for the twelve months ending in the quarter a year ago Kaitlyn Johnson mentioned.

Akers Biosciences Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Operating Income growth Comment
Akers Biosciences Inc ' has realized cumulative trailing twelve months Operating Loss of $ -11 millions in the Sep 30 2020 period.
The results are worsening as the cumulative Operating Loss is becoming larger from $ -9.39 millions in TTM ending quarter Jun 30 2020 and $ -3.66 millions from the TTM period ending Sep 30 2019.

Akers Biosciences Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Operating Income Growth
Biotechnology & Drugs Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
AKER's Operating Income Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for AKER's Competitors
Operating Income Growth for Akers Biosciences Inc 's Suppliers
Operating Income Growth for AKER's Customers

You may also want to know
AKER's Annual Growth Rates AKER's Profitability Ratios AKER's Asset Turnover Ratio AKER's Dividend Growth
AKER's Roe AKER's Valuation Ratios AKER's Financial Strength Ratios AKER's Dividend Payout Ratio
AKER's Roa AKER's Inventory Turnover Ratio AKER's Growth Rates AKER's Dividend Comparisons



Companies with similar Operating Income no change for the quarter ending Sep 30 2020 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Sep 30 2020
Mallinckrodt Plc  400.00 %$ 400.000 millions
National Vision Holdings Inc   393.11 %$ 393.107 millions
Horizon Therapeutics Public Limited Company  370.15 %$ 370.150 millions
Novocure Limited  289.68 %$ 289.676 millions
Apollo Medical Holdings Inc   271.10 %$ 271.104 millions
Integrated Biopharma Inc  217.02 %$ 217.017 millions
Recro Pharma Inc   214.58 %$ 214.575 millions
Laboratory Corporation Of America Holdings  208.06 %$ 208.061 millions
Fourth Wave Energy Inc   201.68 %$ 201.678 millions
Owens and Minor Inc   198.46 %$ 198.463 millions
Antares Pharma Inc   193.09 %$ 193.086 millions
Protokinetix Inc   185.13 %$ 185.126 millions
Repligen Corp  163.20 %$ 163.197 millions
Catalent Inc   136.92 %$ 136.919 millions
The Pennant Group Inc   132.50 %$ 132.503 millions
Becton Dickinson And Company  131.82 %$ 131.818 millions
Quest Diagnostics Inc  129.39 %$ 129.393 millions
Oxford Immunotec Global Plc  125.41 %$ 125.410 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

OSH's Profile

Stock Price

OSH's Financials

Business Description

Fundamentals

Charts & Quotes

OSH's News

Suppliers

OSH's Competitors

Customers & Markets

Economic Indicators

OSH's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071